Drinking to Excess? Psychedelics Can HelpShutterstock

Drinking to Excess? Psychedelics Can Help

Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism.
Study Finds Psilocybin Anti-Depression Effects Last at Least One YearShutterstock

Study Finds Psilocybin Anti-Depression Effects Last at Least One Year

A year after a Johns Hopkins psilocybin-assisted therapy study, researchers find the number of people who benefited from receiving two doses actually increased.
Inside a 5-MeO-DMT Retreat: Who Should and Shouldn't Embark on This 'Hero's Journey'Nechayka / Shutterstock

Inside a 5-MeO-DMT Retreat: Who Should and Shouldn’t Embark on This ‘Hero’s Journey’

What do a Tatooine dirt farmer named Luke Skywalker and a would-be psychonaut enrolled at one of Tandava’s psychedelic retreats have in common? Both are about to embark on one heck of a mind-bending “hero’s journey,” at least according…
Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Ketamine Trial for Alcohol Use Disorder Delivers Very Promising ResultsShutterstock

Ketamine Trial for Alcohol Use Disorder Delivers Very Promising Results

Awakn Life Sciences' Head of Ketamine-Assisted Therapy, Professor Celia Morgan, says world’s first controlled trial to investigate efficacy of ketamine-assisted therapy for treatment of Alcohol Use Disorder "paves the way for a paradigm shift."
Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Psychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest ketamine can also treat anxiety among other mental health issues.
Can Psychedelics Treat Alzheimer's Disease?

Can Psychedelics Treat Alzheimer’s Disease?

,
Since substances such as LSD and psilocybin have powerful anti-inflammatory properties, researchers argue that the microbiological action of psychedelics may therefore help fight brain-based symptoms in early Alzheimer’s patients.

Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment

"Psychedelics are well-observed to basically rewire the brain," says Return Health CEO Dr. James Kuo, who is currently working with DMT because it’s shown the most efficacy in neurogenesis.
New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat DepressionShutterstock.com

New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression

“If the results are confirmed in subsequent studies ... antidepressants may no longer need to be stopped for psilocybin treatment,” says MindMed Executive President Dr. Miri Halperin Wernli.
Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized CoShutterstock.com

Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities

“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.